Publications by authors named "Barbara Peruta"

Claim this Profile
I
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying Molecular Alterations.
Silvia Salmoiraghi, Roberta Cavagna, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta

Genes (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Silvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta

Haematologica· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia.
Orietta Spinelli, Manuela Tosi, Barbara Peruta, Marie Lorena Guinea Montalvo, Elena Maino

Mediterr J Hematol Infect Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma.
Sergio Cortelazzo, Tamara Intermesoli, Elena Oldani, Fabio Ciceri, Giuseppe Rossi, Barbara Peruta

Ann Hematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Renato Bassan, Orietta Spinelli, Elena Oldani, Tamara Intermesoli, Manuela Tosi, Barbara Peruta

Blood· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Orietta Spinelli, Barbara Peruta, Manuela Tosi, Vittoria Guerini, Anna Salvi

Haematologica· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis